Merrimack Pharmaceuticals Inc – Underwriting Agreements – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from SCHEDULE 13G 1 page Joint Filing Agreement

from SC 13G/A 1 page Joint Filing Agreement

from S-3 34 pages Merrimack Pharmaceuticals, Inc. $40,000,000 of Shares of Common Stock, Par Value $0.01 Per Share Sales Agreement

from S-3ASR 37 pages Merrimack Pharmaceuticals, Inc. $40,000,000 of Shares of Common Stock, Par Value $0.01 Per Share Sales Agreement

from 8-K 44 pages J.P. Morgan Securities LLC Merrill Lynch, Pierce, Fenner & Smith Incorporated Merrimack Pharmaceuticals, Inc. 4.50% Convertible Senior Notes Due 2020 Underwriting Agreement

from 8-K 43 pages J.P. Morgan Securities LLC Merrill Lynch, Pierce, Fenner & Smith Incorporated Merrimack Pharmaceuticals, Inc. 5,000,000 Shares of Common Stock, Par Value $0.01 Per Share Underwriting Agreement

from POS AM 31 pages J.P. Morgan Securities LLC Merrimack Pharmaceuticals, Inc. [·] Shares of Common Stock, Par Value $0.01 Per Share Underwriting Agreement

from S-1/A 31 pages J.P. Morgan Securities LLC Merrimack Pharmaceuticals, Inc. [·] Shares of Common Stock, Par Value $0.01 Per Share Underwriting Agreement